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INTRODUCTION
In	women,	cervical	cancer	is	the	third	most	commonly	diag-
nosed	cancer	and	the	fourth	leading	cause	of	cancer	death	in	
females	worldwide,	accounting	for	9%	(529,800)	of	the	total	
new	cancer	cases	and	8%	(275,100)	of	the	total	cancer	deaths	
among	females	in	2008	[1].
Treatment	of	cervical	cancer	depends	on	FIGO	staging.	FIGO	
criteria	is	important	for	pretreatment	staging	and	choice	of	
appropriate	treatment	planning	and	treatment	[2].	The	inclu-
sion	of	CT	or	MRI	scans	in	the	staging	work-up	has	been	ad-
vocated	in	order	to	improve	accuracy	for	cervical	carcinoma	
[2,3].	Cystoscopy	and	sigmoidoscopy	are	necessary	to	confirm	
bladder	and	rectal	invasion	in	cervical	cancer	[4].
Traditional	pretreatment	evaluations	of	patients	with	cervical	
cancer	include	physical	examination,	chest	radiography,	cys-
toscopy,	intravenous	urography,	sigmoidoscopy,	and	barium	
enema	[2,3].	However,	imaging	modalities	(CT,	MRI	scan)	and	
endoscopy	(cystoscopy,	sigmoidoscopy)	are	not	included	in	
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Objective:	A	recent	revision	of	the	FIGO	staging	system	does	not	recommend	the	mandatory	use	of	cystoscopy	and	
sigmoidoscopy.	The	objective	of	this	study	was	to	assess	the	clinical	utility	of	CT	or	MRI	scans	for	ruling	out	bladder	or	rectal	
invasion	and	determine	the	indication	for	endoscopy	in	patients	with	cervical	cancer.
Methods: We	retrospectively	reviewed	769	patients	with	cervical	cancer,	who	underwent	imaging	and	endoscopic	work-up	
between	January	1997	and	December	2010.	Using	endoscopy	as	the	standard	reference	for	comparison,	we	calculated	the	
sensitivity,	specificity,	positive	predictive	value	(PPV),	negative	predictive	value	(NPV),	and	accuracy	of	the	imaging	modality	for	
bladder	or	rectal	invasion.
Results: The	CT	scan	showed	68.2%	and	85.7%	for	sensitivity	and	96.4%	and	98.9%	for	specificity	in	detecting	bladder	and	rectal	
invasion,	respectively.	CT	scan	provided	a	low	PPV	(51.7%,	54.5%)	and	a	high	NPV	(98.2%,	99.8%).	MRI	scan	showed	88.0%	and	
75.0%	for	sensitivity	and	93.1%	and	98.9%	for	specificity	in	detecting	bladder	and	rectal	invasion,	respectively.	MRI	scan	provided	
a	low	PPV	(35.6%,	42.9%)	and	a	high	NPV	(99.4%,	99.7%).	The	accuracies	of	CT	and	MRI	scans	in	identifying	bladder	invasion	were	
94.9%	and	92.8%,	respectively.	The	accuracies	of	CT	and	MRI	in	identifying	rectal	invasion	were	98.7%	and	98.6%,	respectively.	
Conclusion: The	results	of	this	study	demonstrate	that	additional	invasive	endoscopy	is	not	necessary	for	patients	who	present	
with	no	invasion	on	imaging	work-up,	and	therefore,	endoscopy	should	be	considered	a	tool	for	confirming	cases	that	are	
positive	for	invasion	based	on	imaging	work-up.
Keywords:	Computed	tomography,	Cystoscopy,	Magnetic	resonance	imaging,	Sigmoidoscopy,	Uterine	cervical	neoplasms
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the	recent	FIGO	guidelines	for	routine	pretreatment	staging	
of	cervical	cancer	[5].	Recent	FIGO	staging	system	for	the	cer-
vix	encourages	the	use	of	CT	and	MRI	scans,	but	cystoscopy	
and	sigmoidoscopy	were	classified	as	optional	modalities	and	
are	not	recommended	as	mandatory	examinations.	However,	
there	are	no	recommendations	regarding	which	patients	
should	receive	endoscopy	as	an	alternative	examination.
We	carried	out	a	retrospective	analysis	of	cervical	cancer	
patients	who	underwent	imaging	work-up	and	endoscopy	
before	radiotherapy	to	determine	the	clinical	utility	of	CT	or	
MRI	scans	for	ruling	out	bladder	or	rectal	invasion,	and	the	in-
dications	of	endoscopy	for	patients	with	cervical	cancer.
MATERIALS AND METHODS
Between	January	1997	and	December	2010,	1,610	patients	
with	biopsy-confirmed	cervical	cancer	were	treated	by	the	
radiation	oncology	department	of	Samsung	Medical	Center,	
Seoul,	Korea.	Among	these	patients,	we	retrospectively	re-
viewed	the	records	of	769	patients	who	underwent	imaging	
work-ups	such	as	CT	(503	patients)	or	MRI	(749	patients)	scans,	
and	473	patients	who	underwent	both	CT	and	MRI	in	addition	
to	the	standard	FIGO	staging	work-up.	Among	them,	endos-
copies	such	as	cystoscopy	or	sigmoidoscopy	were	done	in	
590	patients	and	735	patients,	respectively.	In	Samsung	Medi-
cal	Center,	if	there	is	no	contraindication,	it	is	routine	practice	
to	conduct	imaging	and	endoscopy	for	all	patients	with	cervi-
cal	cancer.	We	analyzed	data	regarding	age,	tumor	size,	stage,	
lymph	node	involvement,	menopause	status,	and	squamous	
cell	carcinoma	antigen	(SCC-Ag).
Considering	endoscopy	as	the	standard	reference	investiga-
tion,	the	sensitivity,	specificity,	positive	predictive	value	(PPV),	
negative	predictive	value	(NPV),	and	accuracy	of	CT	and	MRI	
scans	for	bladder	and	rectal	invasion	were	determined.
Each	patient	underwent	pretreatment	imaging	work-up	of	
the	abdominopelvic	area	and	endoscopy	of	the	bladder	or	
rectum.	CT	(Lightspeed	VCT*	XTe,	GE	Healthcare,	Buckingham-
shire,	UK)	scans	were	performed	using	contiguous	axial,	sag-
ittal,	and	coronal	5-mm	thickness	slices	after	administration	
of	contrast	medium.	MRI	scans	were	performed	using	a	1.5	T	
unit	(Achieva,	Phillips	Medical	System,	Eindhoven,	Netherland;	
Signa	HDe,	GE	Healthcare).	The	cardiac	or	torso	coil	was	used	
in	the	supine	position	from	the	pelvis	to	the	abdomen.	The	CT	
scan	criteria	for	bladder	or	rectal	invasion	included	the	focal	
loss	of	the	periorgan	fat	plane	between	the	bladder	or	rectum	
and	the	growth,	accompanied	by	asymmetrical	wall	thicken-
ing,	nodular	indentations	along	the	bladder	or	rectal	wall,	and	
intraluminal	tumor	masses.	MRI	findings	of	wall	irregularity	
with	heterogeneous	signal,	enhancement	with	thickening	
and	nodularity,	loss	of	fat	plane	or	mass	protruding	into	the	
bladder	or	rectal	lumen	were	interpreted	as	positive	invasion.
Twenty	five	out	of	65	patients	(38.5%)	and	7	out	of	16	pa-
tients	(43.8%)	were	pathologically	confirmed	by	cystoscopy	
or	sigmoidoscopy	when	the	bladder	or	rectum	invasion	sus-
pected	on	image	work-up.	Endoscopy	was	considered	the	
gold	standard	for	determining	the	presence	of	bladder	or	
rectal	invasion.	In	all	cases,	cystoscopy	and	sigmoidoscopy	
were	performed	by	an	urologist	and	gastroenterologist,	re-
spectively.	Flexible	or	rigid	cystoscopy	was	used	for	bladder	
investigation,	and	fiberoptic	sigmoidoscopy	was	used	for	
rectal	examination	with	biopsy	for	pathological	confirmation.	
Endoscopically	directed	biopsy	specimens	were	taken	from	all	
areas	in	the	bladder	and	rectum	that	were	suspected	of	can-
cer	development.
Seven	hundred	fifty	three	patients	received	radiotherapy.	
Most	of	these	patients	(603	patients,	80.1%)	received	5,040	
cGy	of	external	beam	radiotherapy,	and	359	patients	(47.7%)	
underwent	additional	brachytherapy.	A	total	of	450	patients	
underwent	combined	chemotherapy	with	radiotherapy.	Six-
teen	patients	who	did	not	receive	radiotherapy	were	treated	
with	palliative	aim.	424	patients	did	not	receive	brachytherapy	
of	patients	with	radiotherapy.	Among	these	patients	who	did	
not	received	brachytherapy,	most	patients	underwent	post-
operative	adjuvant	radiotherapy	or	palliative	radiotherapy.
We	evaluated	the	sensitivity,	specificity,	PPV,	NPV,	and	ac-
curacy	of	CT	and	MRI	findings	for	the	diagnosis	of	bladder	or	
rectal	invasion,	by	comparing	the	frequencies	of	each	imag-
ing	work-up	with	the	final	endoscopic	biopsy.	The	sensitivity,	
specificity,	PPV,	NPV,	and	accuracy	of	CT	scans	for	bladder	or	
rectal	invasion	were	calculated	using	the	following	formulae:	
Sensitivity=
Number	of	true	positives
Number	of	true	positives+Number	of	false	negatives
Specificity	=
Number	of	true	negatives
Number	of	true	negatives+Number	of	false	positives
PPV	=
Number	of	true	positives
Number	of	true	positives+Number	of	false	positives
NPV=
Number	of	true	negatives
Number	of	true	negatives+Number	of	false	negatives
Accuracy=
Number	of	true	positives+Number	of	true	negatives
Number	of	true	positives+False	positives+	
False	negatives+True	negativesBae Kwon Jeong, et al.
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RESULTS
Seven	hundred	sixty	nine	are	reviewed	and	their	charac-
teristics	are	given	in	Table	1.	The	median	age	of	the	patients	
was	50	years	(range,	20	to	85	years)	and	the	median	follow-up	
was	37	months	(range,	1	to	162	months).	Of	769	patients,	29	
(3.8%),	50	(6.5%),	and	25	patients	(3.3%)	had	bladder	invasion	
on	CT,	MRI	scan,	and	cystoscopy,	respectively.	Rectal	invasion	
was	identified	in	11	(1.4%),	14	(1.8%),	and	7	patients	(0.9%)	on	
CT,	MRI	scan,	and	sigmoidoscopy,	respectively.	The	results	for	
each	of	the	imaging	modalities	are	given	in	Tables	2	and	3,	
with	endoscopic	findings	considered	as	the	gold	standard.	CT	
and	MRI	scans	revealed	bladder	invasion	in	15	and	12	patients,	
respectively,	who	had	endoscopically	confirmed	bladder	inva-
sion	(true-positive	for	bladder	invasion)	and	CT	and	MRI	both	
revealed	rectal	invasion	in	6	patients,	respectively,	who	had	
endoscopically	confirmed	rectal	invasion	(true-positive	for	
rectal	invasion).	Thus,	14	patients	demonstrated	bladder	inva-
sion	on	CT	scan	only	and	38	patients	demonstrated	bladder	
invasion	on	MRI	scan	only	(false-positive	for	bladder	invasion).	
Five	patients	demonstrated	rectal	invasion	on	CT	scan	only	
and	8	patients	demonstrated	rectal	invasion	on	MRI	scan	only	
(false-positive	for	rectal	invasion).	Seven	and	3	patients	who	
had	cystoscopically	confirmed	invasion	(false-negative	blad-
der	invasion)	did	not	show	any	invasion	on	CT	and	MRI	scan,	
respectively.	For	each	image	modality,	there	was	one	patient	
who	showed	no	invasion,	but	had	sigmoidoscopically	con-
firmed	invasion	(false-negative	rectal	invasion).	Finally,	in	2	pa-
tients	showing	no	bladder	involvement	on	CT	and	MRI	scan,	
Table 1. Patient characteristics 
Attribute No. (%)
No. of patients 769
Age (yr) 20-85 (median, 53)
   ≤50   332 (43.2)
   >50  437 (56.8)
FIGO stage
   IA  8 (1.0)
   IB 314 (40.8)
   IIA  134 (17.4)
   IIB 207 (26.8)
   IIIA  5 (0.7)
   IIIB  60 (7.8)
   IVA 25 (3.3)
   IVB  16 (2.1)
Histopathology
   Squamous 627 (81.5)
   Adenocarcinoma 96 (12.5)
   Others 46 (5.9)
Lymph node involvement
   Positive 378 (49.2)
   Negative 390 (50.7)
Tumor size* (cm)
   ≤4   260 (33.8)
   >4    509 (66.2)
Bladder invasion 25/590 (4.2)
Rectal invasion 7/735 (1.0)
*Median, 4 cm; mean, 4.3±1.7 cm.
Table 3. Diagnostic ability of imaging modalities in rectal or bladder invasion
　 Sensitivity Specificity PPV NPV Accuracy
Bladder invasion
   CT 68.2 96.4 51.7 98.2 94.9
   MRI 88.0 93.1 35.6 99.4 92.8
   CT & MRI  90.9 91.7 39.2 96.6 -
Rectal invasion
   CT 85.7 98.9 54.5 99.8 98.7
   MRI 85.7 98.9 42.9 99.7 98.6
   CT & MRI  85.7 99.1 42.9 99.8 -
PPV, positive predictive value; NPV, negative predictive value.
Values are presented as percentage (%).
Table 2. Correlation of imaging findings with endoscopic findings for 
rectal and bladder invasion
Bladder invasion Rectal invasion
CT MRI CT MRI
True positive 15 12 6 6
False positive 14 38 5 8
True negative 375 509 466 701
False negative 7 3 1 1Indications for endoscopy according FIGO staging for cervical cancer 
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bladder	invasion	was	confirmed	by	cystoscopy.	As	shown	in	
Table	3,	CT	scan	showed	a	sensitivity	of	68.2%	and	85.7%,	and	
a	specificity	of	96.4%	and	98.9%,	for	detecting	bladder	and	
rectal	invasion,	respectively.	CT	scan	had	a	low	PPV	(51.7%	and	
54.5%)	and	a	high	NPV	(98.2%	and	99.8%).	MRI	scan	showed	a	
sensitivity	of	88.0%	and	85.7%,	and	a	specificity	of	93.1%	and	
98.9%	for	detecting	bladder	and	rectal	invasion,	respectively.	
MRI	scan	had	a	low	PPV	(35.6%	and	42.9%)	and	a	high	NPV	
(99.4%	and	99.7%).	The	accuracies	of	the	imaging	modalities	
in	detecting	the	bladder	and	rectal	invasion	are	given	in	Table	3.	
DISCUSSION
In	FIGO	staging,	some	studies	concluded	that	the	use	of	im-
aging	is	not	superior	to	physical	examination	[2,6].	In	contrast,	
many	studies	have	suggested	that	imaging	is	an	important	
work-up	tool	and	should	be	included	in	staging	[3,7-11].	
Cystoscopy	and	sigmoidoscopy,	previously	categorized	as	
mandatory	investigations,	were	reclassified	as	optional	in-
vestigations	in	a	recent	revision	of	FIGO	staging	[5].	Since	the	
2009	revision	of	FIGO	staging,	a	few	studies	have	explored	the	
identification	of	patients	who	will	need	endoscopy	[12-14].	
The	present	study	therefore	had	two	objectives.	The	primary	
objective	was	to	establish	how	to	identify	patients	who	re-
quired	cystoscopy	or	sigmoidoscopy	according	to	the	revised	
FIGO	staging.	The	secondary	objective	was	to	demonstrate	
the	accuracy	of	CT	and	MRI	scans	for	pretreatment	diagnosis	
of	bladder	and	rectum	invasion.
Based	on	previous	studies,	the	sensitivities,	specificities,	
PPVs,	NPVs,	and	accuracies	of	CT	and	MRI	scanning	for	bladder	
or	rectal	invasion	were	about	40-100%,	92-100%,	40-100%,	85-
100%,	and	86-98%,	respectively	[4,12,14-17].	The	results	of	this	
study	correspond	well	with	those	of	previous	studies	(Table	4),	
with	the	exception	of	a	few	differences	in	sensitivity.	In	this	study,	
the	NPV	was	high	enough	so	that	additional	invasive	endos-
copy	was	not	necessary	for	patients	who	presented	without	
invasion	in	imaging	work-up	(CT,	MRI	scan).	Endoscopy	should	
be	considered	as	a	tool	for	confirming	invasion	when	patients	
were	positive	for	invasion	based	on	imaging	work-up	even	
though	CT	and	MRI	scans	are	not	as	effective	for	the	purpose	
of	diagnosis	due	to	low	sensitivity	and	PPV.	These	results	sug-
gest	that	there	are	advantages	to	using	imaging	modalities	for	
the	physician	and	patients,	and	that	imaging	offers	additional	
cost	benefits.	There	is	no	evidence	that	the	low	sensitivity	of	
imaging	can	be	increased	by	simultaneously	using	CT	and	
MRI	scans	as	shown	in	Table	3.	MRI	scans	may	be	instrumental	
as	a	diagnostic	tool	to	evaluate	myometrial	invasion	or	lymph	
node	involvement,	but	it	has	no	additional	benefit	as	part	of	
the	confirmation	process	for	bladder	or	rectal	invasion.
Fig.	1	shows	a	false-negative	image	from	an	MRI	scan	and	
endoscopy.	There	is	no	evidence	of	bladder	invasion	on	the	
CT	and	MRI	scan,	but	cystoscopy	revealed	that	the	patient	was	
positive	for	invasion.	False	negative	in	CT	or	MRI	is	a	rare	case	
in	this	study	and	in	previous	studies	which	conducted	similar	
purpose	with	the	current	study.	The	false	negative	finding	in	
this	case	may	have	been	the	result	of	poor	image	quality	or	
focal	invasion	in	between	the	CT	slices,	so	additional	invasive	
endoscopy	is	not	recommended	to	check	the	invasion	for	pa-
tients	without	invasion	on	imaging	work-up.
The	findings	of	this	study	are	significant	because	they	are	
based	on	a	larger	patient	sample	than	those	of	previous	stud-
ies.	In	addition,	we	analyzed	the	accuracy	and	indications	of	
two	imaging	modalities,	CT	and	MRI,	for	the	diagnosis	of	blad-
der	and	rectal	invasion.
There	are	some	limitations	to	this	single	institution	retro-
spective	study.	First	is	that	the	number	of	patients	in	a	specific	
group,	such	as	stage	IV,	was	too	small	for	analysis	and	stage	
IIA	was	too	large	to	bring	about	selection	bias.	Second	is	that	
this	study	does	not	include	cervical	cancer	patients	treated	
Table 4. Summary of studies showing the capabilities of CT alone or CT and MRI in bladder invasion
Study No. of patients Sensitivity (%) Specificity (%) PPV (%) NPV (%) Accuracy (%)
Janus et al. [16] 22 40 100 100 85 86
Sundborg et al. [14] 42 100 96 60 100 96
Liang et al. [4]. 100 100 98 80 100 98
Sharma et al. [12] 305 100 92 40 100 92
This study 411 68.2 96.4 51.7 98.2 94.9
Chung et al. [15]* 296 100 98 57 100 98
This study* 397 90.9 91.7 39.2 96.6 -
PPV, positive predictive value; NPV, negative predictive value.
*Combined values for CT and MRI scans. Bae Kwon Jeong, et al.
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with	surgery	or	chemotherapy	only.	Another	limitation	is	that	
endoscopy	was	not	performed	in	all	patients,	but	was	more	
likely	to	be	used	in	patients	who	were	suspected	of	having	
bladder	or	rectal	invasion	based	on	imaging	work-up	or	physi-
cal	examination.
In	conclusion,	if	there	is	no	evidence	of	invasion	on	imaging	
work-up,	endoscopy	is	not	necessary	as	an	invasive	diagnos-
tic	modality.	However,	if	there	is	any	evidence	of	invasion	on	
imaging	work-up,	endoscopy	is	necessary	to	obtain	an	accu-
rate	prognosis	for	appropriate	treatment.	Patients	prefer	non-
invasive	diagnostic	methods,	which	have	fewer	side	effects.	
Therefore,	future	work	should	focus	on	the	use	of	CT	virtual	
endoscopy,	which	can	be	used	in	place	of	invasive	endoscopy.
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